Your browser doesn't support javascript.
loading
Ultra-low dose rituximab as add-on therapy in anti-MDA5-positive patients with polymyositis /dermatomyositis associated ILD.
Mao, Meng-Meng; Xia, Shu; Guo, Bing-Peng; Qian, Wei-Ping; Zheng, Ze-Xuan; Peng, Xiao-Min; Chen, Rong-Chang; Luo, Qun; Han, Qian.
Afiliación
  • Mao MM; State Key Laboratory of Respiratory Disease, National Clinical Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, PR China.
  • Xia S; State Key Laboratory of Respiratory Disease, National Clinical Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, PR China.
  • Guo BP; State Key Laboratory of Respiratory Disease, National Clinical Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, PR China.
  • Qian WP; State Key Laboratory of Respiratory Disease, National Clinical Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, PR China.
  • Zheng ZX; State Key Laboratory of Respiratory Disease, National Clinical Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, PR China.
  • Peng XM; State Key Laboratory of Respiratory Disease, National Clinical Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, PR China.
  • Chen RC; State Key Laboratory of Respiratory Disease, National Clinical Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, PR China; Shenzhen People's Hospital, Shenzhen, Guangdong, China.
  • Luo Q; State Key Laboratory of Respiratory Disease, National Clinical Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, PR China.
  • Han Q; State Key Laboratory of Respiratory Disease, National Clinical Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, PR China. Electronic address: hanqian1020@yahoo.com.
Respir Med ; 172: 105983, 2020 10.
Article en En | MEDLINE | ID: mdl-33032789
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_immune_disorders / 6_malignant_skin_melanoma / 6_musculoskeletal_diseases_rheumatic_disorders / 6_other_respiratory_diseases / 6_skin_diseases Asunto principal: Autoanticuerpos / Polimiositis / Enfermedades Pulmonares Intersticiales / Dermatomiositis / Rituximab / Helicasa Inducida por Interferón IFIH1 Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Respir Med Año: 2020 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_immune_disorders / 6_malignant_skin_melanoma / 6_musculoskeletal_diseases_rheumatic_disorders / 6_other_respiratory_diseases / 6_skin_diseases Asunto principal: Autoanticuerpos / Polimiositis / Enfermedades Pulmonares Intersticiales / Dermatomiositis / Rituximab / Helicasa Inducida por Interferón IFIH1 Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Respir Med Año: 2020 Tipo del documento: Article